US Stock MarketDetailed Quotes

CUE Cue Biopharma

Watchlist
  • 1.230
  • -0.010-0.81%
Close Feb 28 16:00 ET
  • 1.140
  • -0.090-7.32%
Post 20:01 ET
77.92MMarket Cap-1.35P/E (TTM)

Cue Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cue Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.268M--
--2024/Q4-- / 1.701M--
--2024/Q33.336M / 1.520M--
--2024/Q22.658M / 1.289M--
--2024/Q11.717M / 1.213M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.268M--
--2024/Q4-- / 1.701M--
--2024/Q33.336M / 1.520M--
--2024/Q22.658M / 1.289M--
--2024/Q11.717M / 1.213M--

Unlock Free Earnings Estimates

Cue Biopharma Earnings Reports

  • Cue Biopharma | 10-Q: Q3 2024 Earnings Report

    Nov 14, 2024 16:08 ET

  • Cue Biopharma | 8-K: Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights

    Nov 14, 2024 16:07 ET

  • Cue Biopharma | 10-Q: Q2 2024 Earnings Report

    Aug 14, 2024 16:07 ET

  • Cue Biopharma | 10-Q: Q1 2024 Earnings Report

    May 9, 2024 16:05 ET

    • Read more

    Trending Stocks

    Top Gaining Chinese Stocks Top Gaining Chinese Stocks
    No. Symbol % Chg
    LINTEX
    920106
    +30.00%
    LINGOOD
    833284
    +29.98%
    NTGEC
    870436
    +29.98%
    4
    CG MED EQUIP.
    838810
    +29.97%
    5
    Jiayu Holding
    300117
    +20.48%
    Log In for the Full List
    Unlock Now
    Investment Course
    Top 5 Industries for Stock Trading under Trump's Second Term
    Stocks & Industries to Watch Under Trump's Second Presidency
    With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
    Discussing
    Tesla's earnings caused fluctuations, what's your market outlook？
    Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
    TSLA earnings preview: Grab rewards by guessing the opening price!